Alex Jung
Partner/Managing Director, Health & Life Sciences, Parthenon-EY
Professional experience
Alex Jung
Partner &
Managing
Director
►
Balraj is a Partner in EY’s Health and Life Sciences practices who brings with over 30 years of
experience in healthcare, health IT, life sciences and public policy.
►
Prior to joining EY, Alex was the Divisional Vice President of Corporate Strategy for Walgreens. During
her tenure there, she architected the company’s healthcare strategy, including the development of the
transformed community pharmacy model, acquisitions in eCommerce, specialty, infusion services,
retail clinics and Alliance Boots as well as contract negotiations with Caremark and ESI for the
enterprise.
►
Most recently she has worked with many Fortune 100 companies on M&A, growth and innovation
strategies and international expansion. She specializes in asset repurposing and new platform
commercialization, including pricing strategies and network negotiations.
►
Before joining Walgreens, she was the healthcare practice leader for AonHewitt and has also worked in
leadership roles at Mercer, WatsonWyatt and Arthur Andersen.
155 N Wacker
Chicago, IL 60607
Mobile: +1 847-722-3482
Email: [email protected]
Fields of expertise


Portfolio asset review and
repositioning/improvement of core
assets, growth platform design (new
business models), operational process
improvement and cost reduction or
asset repurposing/divesture
Ideation and design of new value
propositions, operating models and
economic/pricing models for
commercialization

New device or drug launches

M&A and divestiture or capital
redeployment around low performing
assets
Education
 B.S., Business Management,
Northeastern Illinois University,
Northwestern University
 Licensed broker health, accident/life
 Certified Project Manager (CMP) and
trained in Juran and W. Edward
Deming Quality Processes/Lean
 CEBS, International Foundation of
Confidential
– All Rights
Reserved – Ernst & Young 2008
Employee
Benefits
Industry expertise
►
►
Key sectors of the global life sciences industry
►
Healthcare providers/hospitals, health IT platforms, public/social service agencies
►
Global pharmaceuticals, Bio-technology companies & Biosimilar/Generic manufacturers
►
Medical Devices, Diagnostics & Digital Health companies
Key sectors of the U.S. health care delivery system
►
Providers (Hospitals/AMCs, Integrated Delivery Networks/ACOs, Pharmacies)
►
Payers (Commercial MCOs, Medicare, State Medicaid, Public and private exchanges)
►
Intermediaries (PBMs, Specialty Pharmacy & Distributors)
Select experiences
►
Development of growth strategies for the largest US health system and payer, innovation and new value
propositions around employers, exchanges and pharmacy to accommodate new specialty drugs
►
Development of disease specific centers of excellence, including oncology, brain injuries/disorders,
serious chronic diseases (HIV/AIDs, Hep-C, MS, RA)
►
Development of new product designs for medical devices such as diagnostic cardiology, maternal/fetal
and patient monitoring, magnetic and RFID enabled nanotechnology, female reproductive organ repair
►
Development of new drug and device launches and pricing strategies for Hep-C, HIV/AIDs, neurological
disorders (migraine, pseudo-bulbar affect, anti-seizure/neuro-modulation)
►
Development of new business models, global expansion strategies and ministry of health negotiations
►
Packaging and divestiture of healthcare IT platforms, nursing services, provider practices, PBMs,
pharmacies, medical devices, and many acquisitions in the US and abroad
Alex Jung – Partner/Managing Director
Direct:
Mobile:
Email:
Office:
312-879-2778
847-722-3482
[email protected]
155 N Wacker Drive, Chicago
Alex is a partner in Parthenon-EY Strategy where she works
primarily on growth strategy projects. She helps clients define and
implement their business strategy and build organizational
capabilities to deliver sustainable business results both through
organic and inorganic approaches. She is a thought leader in the
industry and specializes in asset repurposing and optimizing value
propositions.
Profile Summary
Significant Experience
Alex Jung is a partner in Parthenon EY. Prior to joining EY, she was the Senior
Vice President leading Walgreens Corporate Strategy based in Deerfield, IL.
Alex has worked globally with Fortune 500 companies and health systems and has
developed and implemented large scale strategy, operations and financial projects.
She specializes in asset repurposing and value proposition development. Her
domain expertise in healthcare spans from hospital/clinic operations, IT and digital
platforms, clinical intervention/wellness programs, benefit plan designs,
commercialization strategy for new products and growth strategies including M&A.
Mrs. Jung has over 30 years of experience working on strategic growth and risk
mitigation engagements. She began her career with Arthur Andersen and after ten
years moved into consulting with Mercer as the leader of the National Health Care
Analysis Unit, helping to architect one of the first data analytics platforms.
She later became the Managing Director for the General Board of the United
Methodist Church. Alex returned to consulting to lead the health care practice at
Aon Consulting and their significant growth into the number one consulting firm in
the space after the acquisition of Hewitt Associates.
She is a regular speaker at events such as the California Governor’s Women’s
Conference, World Healthcare Congress, Midwest Business Group on Health, Crain’s
Annual Health Care Conference, the Benefits Management Expo, the Self Insurance
Association of America, John Marshall Law School, and HRMAC where she serves
as the Chair for the Total Rewards Interest Group. She sits on the advisory board of
the Michael Reese Health Trust and the Healthy Chicago initiative. She is also a
member of the Board of Directors for the Respiratory Health Association and Chair
of the Health and Wellness Council of the City of Chicago’s Chamber of Commerce.
She has performed work on several large scale transactions, mergers and
acquisitions including the divestiture of Walgreen’s PBM, acquisition of
AllianceBoots and other assets while at Walgreens. She also architected the health
and wellness strategy for the company as part of the pharmacy transformation.
She has developed new business models, operating/economic models, IT business
requirements, labor and productivity models. She has redesigned various health
care delivery models/footprints, product launches/service value propositions,
pricing/commercialization strategies, new medical device functionality, and IT
platforms.
She has been quoted in numerous articles in Kennedy Research, Forrester, Forbes
Magazine, The Chicago Tribune, Business Insurance, Workforce Management
Magazine, Crain’s Chicago Business and other industry publications. She is on the
editorial board of Inside Patient Care magazine and advises research organizations
around the world.
Education
Knowledge & Skills
Industries
• B.S., Business Management, Northeastern
• Corporate and business strategy, asset
•
•
•
•
•
•
•
•
•
Illinois University, Northwestern University
Licensed broker health, accident and life
Certified project manager (CMP) and trained in
Juran and W. Edward Deming Quality Process
CEBS, International Foundation of Employee
Benefits
•
•
•
•
repurposing and business model redesign
Operations and process improvement
Mergers & acquisitions
Clinical program development
Employee benefits strategy, plan design and
funding strategies
Healthcare providers/hospitals/retail clinics
Managed care/Insurance payers
Life Sciences/Pharmaceuticals
Medical Device/Diagnostics/HCIT
Clinical Interventions/wellness
Consumer Products/Retail